SCHEMBL26214622

SCHEMBL26214622

Cc1ccc([Si](c2ccccc2)(c2ccccc2)c2cccc(-c3cc(-n4c5ccccc5c5ccccc54)nc(-n4c5ccccc5c5ccccc54)n3)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.34
KDM4E B2RXH2 5/20 0.34
MAPT P10636 5/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
HPGD P15428 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
FLT3 P36888 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
AGTR1 P30556 1/20 0.32
GAA P10253 3/20 0.32
PIK3CA P42336 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CYP3A4 P08684 1/20 0.31
LMNA P02545 5/20 0.31
TP53 P04637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26226168 0.94 ALDH1A1 (0.33) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL23622198 0.93 PIK3CA (0.35) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL22038582 0.93 PIK3CA (0.35) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL26004924 0.91 MAPT (0.34) ALDH1A1KDM4EMAPTKMT2AMEN1
SCHEMBL25449301 0.91 PIK3CA (0.34) KDM4EMAPTL3MBTL1MAPK1NPSR1
SCHEMBL25752925 0.91 PIK3CA (0.34) KDM4EMAPTL3MBTL1MAPK1NPSR1
SCHEMBL23622161 0.90 KDM4E (0.38) ALDH1A1KDM4EMAPTHPGDL3MBTL1
SCHEMBL25752923 0.90 PIK3CA (0.34) KDM4EMAPTL3MBTL1MAPK1NPSR1
SCHEMBL23622194 0.89 PIK3CA (0.33) PIK3CA
SCHEMBL23622685 0.89 MAPT (0.35) ALDH1A1KDM4EMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329089-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-12 US disclosed
US-20230292539-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-14 US disclosed
US-20230292593-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-14 US disclosed
US-20230279029-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230329089-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NR1H2, OXER1, NR1H3 ALDH1A1 669/4885KDM4E 2635/4885MAPT 4351/4885
US-20230279029-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, EHD1 ALDH1A1 1685/4885KDM4E 3331/4885MAPT 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.